Abbott Laboratories (ABT) stock analysis

In our weekly check, Abbott Laboratories is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 8, red flags: 1.

About Abbott Laboratories

Abbott Laboratories is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ABT.

What our checks show for ABT

Red flags

Warning signs

Strengths

Next earnings report: 2027-01-28

Similar companies

MDT · SYK · BSX · EW · GEHC · DXCM

Questions

What grade does Abbott Laboratories (ABT) have?

In our weekly check, Abbott Laboratories is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 8, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ABT stock?

This week's biggest flags for Abbott Laboratories: Margins falling, Weak revenue growth, Weak EPS growth. In total 9 of 25 checks show a warning or a red flag.

What does Abbott Laboratories do?

Abbott Laboratories is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ABT.

When does Abbott Laboratories report earnings next?

The next earnings report is expected on 2027-01-28. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis